Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
such as leukemia and glioma
C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28
Chemical Name: 2-(2-sulfanylpropanamido)acetic acid
Chemical Name: (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
InChi: InChI=1S/C16H20N2
GSK-1070916 Catalog No.:M10968-10 such as leukemia and gliomaGSK1070916, also known as NMI 900 or GSK 1070916A, is an ATP competitive inhibitor of the serine threonine kinases Aurora B and C with potential antineoplastic activity. Aurora B C kinase inhibitor GSK1070916A binds to and inhibits the activity of Aurora kinases B and C, which may result in inhibition of cellular division and a decrease in the proliferation of tumor cells that overexpress the Aurora kinases B and C. Product information CAS Number:
US$ 114.00
US$ 160.00
US$ 80.00
US$ 90.00
US$ 166.60
US$ 1667.00
US$ 157.50
US$ 1166.00
US$ 80.00
US$ 80.00
US$ 150.00
US$ 2057.00
US$ 1951.50
US$ 1629.50